Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

  • STATUS
    Recruiting
  • participants needed
    48
  • sponsor
    University Hospital, Toulouse
Send
Updated on 19 February 2024
See if I qualify
oxytocin
prader-willi syndrome

Summary

Prospective, randomized, placebo-controlled, double-blind part of the phase III trial to assess the safety and efficacy of 4 weeks oxytocin (OT) administration on oral and social skills in neonates/infants with Prader-Willi Syndrome (PWS) aged less than 3 months at inclusion. Phase III clinical trial.

Details
Condition Prader-Willi Syndrome, Obesity, Obesity
Age 1years or below
Treatment Placebo Comparator, OT
Clinical Study IdentifierNCT04283578
SponsorUniversity Hospital, Toulouse
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Male or female neonate or infant, with PWS genetically confirmed
Age <92 days (plus a tolerance of up to 8 days maximum) (for preterm infants, born before 37 weeks amenorrhea, corrected age will be applied)
Signed informed consent obtained from the parents/holders of parental authority
Parents willing and able to comply with all study procedures

Exclusion Criteria

\. Neonate or infant currently admitted to the emergency care unit for ongoing life-threatening comorbidities like severe respiratory, cardiovascular or neurological abnormalities. 2\. Neonate or infant with prolongation of the QT interval. 3. Neonate or infant without medical insurance. 4. Neonate or infant with hypersensitivity to oxytocin or excipients of the product. 5\. Neonate or infant with concomitant treatment prolonging QT interval 6. Neonate or infant with family history of genetic pathology causing QT interval prolongation. 7\. Neonate or infant with hypokalemia (clinically relevant at the discretion of the doctor). 8\. Neonate or infant participating simultaneously in another interventional study. 9\. Neonates or infants whose parents' situations may jeopardize the interpretation of the results. 10\. Neonates or infants whose parents' refuse video recording, required to respond to the primary objective of the study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

oxytocin
prader-willi syndrome

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.